Skip to main content

Table 2 Univariate and multivariate Cox regression analysis for all-cause mortality

From: The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease

Variables

Univariate

Multivariate

HR

95%CI

P value

HR

95%CI

P value

Age

1.084

1.059–1.110

 < 0.001

1.089

1.060–1.119

 < 0.001

Smoker

1.439

1.031–2.009

0.032

1.575

1.104–2.246

0.012

Hypertension

2.436

1.347–4.404

0.003

   

Previous MI

1.649

1.105–2.459

0.014

   

Previous stroke

1.563

1.099–2.223

0.013

   

ACS

1.310

0.870–1.973

0.196

1.801

1.125–2.883

0.014

LVEF

0.953

0.939–0.968

 < 0.001

0.962

0.943–0.982

 < 0.001

Hemoglobin

0.990

0.984–0.997

0.006

   

SHR

1.993

1.492–2.664

 < 0.001

2.171

1.566–3.008

 < 0.001

TC

0.866

0.754–0.995

0.042

   

TG

0.849

0.698–1.032

0.100

   

HDL-C

0.601

0.331–1.091

0.094

   

LDL-C

0.865

0.731–1.022

0.088

   

hs-CRP

1.007

1.003–1.011

0.011

   

NT-proBNP (per 100 pg/ml)

1.011

1.008–1.013

 < 0.001

1.005

1.001–1.009

0.009

Creatinine

Three-vessel disease

1.007

1.507

1.004–1.010

0.983–2.309

 < 0.001

   

0.060

Left main disease

1.666

1.094–2.537

0.017

1.626

1.045–2.532

0.031

Aspirin

0.456

0.213–0.975

0.043

   

Statin

0.452

0.244–0.837

0.012

0.494

0.248–0.982

0.044

  1. MI myocardial infarction, ACS acute coronary syndrome, LVEF left ventricle ejection fraction, SHR stress hyperglycemia ratio, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, hs‐CRP high‐sensitivity C‐reactive protein, NT-proBNP N-terminal proB-type natriuretic peptide, HR hazard ratio, CI confidential interval